Venous Stents Market: Market Size & Forecast 2026

Venous stents are small, expandable mesh tubes implanted in veins to restore blood flow and treat conditions such as May-Thurner syndrome, chronic venous insufficiency, central venous obstruction, and failing dialysis access fistulas. Unlike arterial stents, venous stents are designed to accommodate the thinner walls, lower pressure, and greater compressibility of veins, which has driven the development of specialized self-expanding and balloon-expandable designs. The market reached roughly $1.3 billion in 2025 and is projected to grow at approximately 7.9% per year, reflecting increasing clinical adoption and broadening indications for venous intervention.

• •Primarily used for iliac vein, central venous, and dialysis access indications
• •Specialized designs differ significantly from coronary or peripheral arterial stents
• •Strong pipeline of next-generation devices targeting specific venous anatomies

The aging global population and rising rates of obesity and sedentary lifestyle are increasing the prevalence of venous diseases, expanding the treatable patient pool. Technological improvements in stent materials, particularly nitinol-based self-expanding platforms, bioabsorbable options, and enhanced radial strength, have improved clinical outcomes and broadened the scope of venous interventions. Growing surgeon confidence in endovascular venous procedures, combined with improved imaging guidance and the recent FDA clearance of dedicated venous stent systems, has further accelerated adoption.

• •Aging population and rising venous disease prevalence expanding patient base
• •Advances in nitinol-based and bioabsorbable stent technology improving outcomes
• •Increased clinical awareness and minimally invasive procedural adoption driving demand

By geography, North America holds the largest market share, supported by advanced healthcare infrastructure, favorable reimbursement pathways, and high disease awareness. Europe follows as the second-largest market, while the Asia-Pacific region represents the fastest-growing territory due to improving healthcare access, rising disposable income, and growing medical tourism for vascular procedures. By stent type, the market comprises bare-metal stents, covered stents, and drug-eluting variants, with self-expanding designs dominating due to their flexibility and better conformity to venous anatomy.

• •North America leads with roughly 45% of the global market
• •Asia-Pacific is the fastest-growing region
• •Self-expanding nitinol stents hold the dominant product segment

What are the recent trends and outlook?

The market is expected to maintain its growth trajectory through 2030, supported by continued device innovation, expanding clinical evidence, and improving reimbursement coverage. Emerging trends include the development of bioabsorbable venous stents that dissolve after restoring vessel patency, combination procedures integrating thrombolytic catheters with stenting, and value-based care models incentivizing effective venous disease management. Pricing pressures in mature markets and the need for broader clinical data in emerging regions present challenges, but increasing physician awareness of venous disease and new product approvals are expected to sustain long-term growth momentum.

• •Bioabsorbable venous stents represent a potential near-term product breakthrough
• •Value-based reimbursement models are influencing adoption patterns in major markets
• •Emerging markets will increasingly contribute to volume growth through 2030